SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, today announced that it is set to join the Russell 3000® Index, which measures the performance of the 3,000 largest U.S. companies based on total market capitalization. The reconstitution of the Russell 3000 Index occurs today.
